Yahoo Web Search

Search results

    • Revving up CAR T and gene therapy development for cancer

      Nature· 22 hours ago

      Mustang Bio is developing next-generation CAR T and gene therapies for cancer and rare genetic diseases, with lead clinical programs in non-Hodgkin lymphoma, chronic lymphocytic leukemia, and X-linked severe combined immunodeficiency.